Overview
- 117 inspections across 116 sites are on record.
- 195 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-20.
At a glance
Inspections
117
Sites
116
Observations
195
Career since
Feb 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Scilex Pharmaceuticals Inc. | 20 May 2026 | Human Drugs | On file |
| Jonathan H. Hughes, M.D. | 4 May 2026 | Medical Devices & Rad Health | |
| Protagonist Therapeutics Inc | 3 Apr 2026 | Human Drugs | On file |
| Ascendis Pharma LLC | 6 Mar 2026 | Human Drugs | On file |
| Richard A. Lafayette, M.D. | 4 Mar 2026 | Human Drugs | On file |
Sites inspected
Scilex Pharmaceuticals Inc.Palo Alto, United States1 insp.
Jonathan H. Hughes, M.D.Las Vegas, United States1 insp.
Protagonist Therapeutics IncNewark, United States1 insp.
Ascendis Pharma LLCPalo Alto, United States1 insp.
Richard A. Lafayette, M.D.Palo Alto, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Scott N Lim3 shared
Rumany C Penn3 shared
Nympha V Florendo3 shared
Karen D Phung3 shared
Joan T Briones2 shared
Cynthia J Tsui2 shared
John A Gonzalez2 shared
Steven B Chiu2 shared
Lucila B Nwatu2 shared
Thea C Grome2 shared
Full investigator report
Get the verbatim findings behind Kristin M Abaonza's 195 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site